注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Northwest Biotherapeutics Inc是一家生物技術公司。該公司專注於開發針對癌症的個性化免疫療法。它開發的一種平台技術DCVax使用激活的樹突狀細胞來調動患者自身的免疫系統來攻擊他們的癌症。該公司的產品線包括DCVax-L和DCVax-Direct。DCVax-L旨在治療可通過手術切除腫瘤的實體瘤癌症。它已經完成了一項針對多形性腦癌(GBM)的DCVax-L的331名患者國際III期試驗。DCVax-Direct旨在治療無法手術的實體瘤。一項40名患者的I期試驗已經完成,包括對十多種癌症的多種治療。其全資子公司包括Flaskworks、Aracaris Ltd、Aracaris Capital, Ltd、Northwest Biotherapeutics B.V.和NW Bio GmbH。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Linda F. Powers | 65 | 2007 | Chairperson, CEO, President, CFO & Chief Accounting Officer |
Alton L. Boynton | 76 | 1998 | Founder, Chief Scientific Officer, Secretary & Director |
J. Cofer Black | 74 | 2016 | Independent Director |
Jerome Galon | - | - | Member of Scientific Advisory Board |
Samir N. Khleif | 60 | - | Member of Scientific Advisory Board |
Martin Cheever | 80 | - | Member of the Scientific Advisory Board |
John F. Smyth | - | - | Member of Scientific Advisory Board |
Henry Brem | 71 | 2005 | Member of Clinical Advisory Board |
Darell D. Bigner | - | 2005 | Member of Clinical Advisory Board |
Steven S. Brem | - | 2005 | Member of Clinical Advisory Board |
Tom Mikkelsen | - | 2005 | Member of Clinical Advisory Board |
Linda M. Liau | 56 | 2005 | Member of Scientific Advisory Board |
Navid Malik | 55 | 2012 | Independent Director |
Pat Sarma | 79 | 2024 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核